重药控股: 关于回购股份进展的公告

Core Viewpoint - The company has approved a share repurchase plan using its own funds and a special loan, with a total amount between RMB 80 million and RMB 100 million, and a maximum repurchase price of RMB 6.6 per share [1][2]. Group 1 - The company held its ninth board meeting and third extraordinary shareholders' meeting on July 10 and July 28, 2025, respectively, to discuss the share repurchase proposal [1]. - The repurchase will be conducted through the Shenzhen Stock Exchange trading system within 12 months from the approval date [1]. - As of July 31, 2025, the company has not yet implemented the share repurchase [1]. Group 2 - The company plans to execute the share repurchase based on market conditions and will fulfill its information disclosure obligations as required [2].